Buy Glenmark Pharmaceuticals, target Rs 610: Manas Jaiswal


Manas Jaiswal of has a buy call on Glenmark Pharmaceuticals with a target price of Rs 610.

The current market price of Glenmark Pharmaceuticals is Rs 578.80.

Time period given by the analyst is Intra Day when Glenmark Pharmaceuticals price can reach defined target.

Manas Jaiswal recommended keeping a stop loss at Rs 567.

Glenmark Pharmaceuticals, incorporated in the year 1977, is a Large Cap company (having a market cap of Rs 16,413.72 Crore) operating in Pharmaceuticals and health care sector.

The company’s top management includes Dr.Brian W Tempest, Mr.Bernard Munos, Mr.D R Mehta, Mr.Glenn Saldanha, Mr.Julio Ribeiro, Mr.Milind Sarwate, Mr.Murali Neelakantan, Mr.Rajesh V Desai, Mr.Sridhar Gorthi, Mrs.B E Saldanha, Mrs.Cherylann Pinto.

The company has Walker, Chandiok & Co.LLP as its auditors.

As on 31-12-2017, the company has a total of 282,168,156 shares outstanding.

Source: Economic Times